Filing Details

Accession Number:
0000059478-19-000103
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-20 15:37:53
Reporting Period:
2019-02-15
Accepted Time:
2019-02-20 15:37:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476151 A Enrique Conterno Lilly Corporate Center
Indianapolis IN 46285
Svp&pres, Lillydiab & Lillyusa No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-15 25,000 $121.00 132,962 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,159 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2018.